VF
NBRV

Virtu Financial’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Virtu Financial’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,103
Closed -$23K – 2557
2022
Q2 		$23K Buy
5,103
+1,921
+60% +$12.5K ﹤0.01% 1309
2022
Q1 		$33K Sell
3,182
-5,196
-62% -$63.1K ﹤0.01% 1226
2021
Q4 		$125K Buy
+8,378
New +$198K 0.01% 1034
2021
Q3 		– Sell
-1,517
Closed -$51K – 2359
2021
Q2 		$51K Buy
1,517
+270
+22% +$10.1K 0.01% 1333
2021
Q1 		$52K Buy
1,247
+365
+41% +$22.7K ﹤0.01% 1431
2020
Q4 		$53K Buy
+882
New +$95.6K 0.01% 1221
2020
Q3 		– Sell
-248
Closed -$42K – 1764
2020
Q2 		$42K Buy
+248
New +$41.4K ﹤0.01% 1026
2018
Q2 		– Sell
-130
Closed -$164K – 2701
2018
Q1 		$164K Sell
130
-157
-55% -$232K 0.01% 1437
2017
Q4 		$429K Buy
+287
New +$454K 0.02% 957

Other funds holding NBRV

VFA
Values First Advisors Gray, Tennessee $192M AUM 24.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial's NBRV Position: Q3 2022 in Review

Virtu Financial sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2022, closing a stake of 5,103 shares — an estimated $23K sold.

Virtu Financial first reported a position in NBRV in Q4 2017 and held it in 9 quarters. The position peaked at $429K in Q4 2017. 13 funds tracked by Wall St. Rank hold NBRV as of Q3 2022.

  • Virtu Financial reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2022 after selling out during the quarter.
  • Virtu Financial sold 5,103 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2022, an estimated $23K.
  • Virtu Financial first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q4 2017 and held it in 9 quarters.
  • Virtu Financial's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $429K in Q4 2017.
  • 13 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2022.

Based on Virtu Financial's 13F filing for Q3 2022, filed 7 Nov 2022.